FCX-013

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	1

51. 全身性強皮症

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03740724 (ClinicalTrials.gov)	December 18, 2019	6/11/2018	A Study of FCX-013Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morp ...	A Phase 1/2 Study of a Combination of FCX-013(Genetically-Modified Autologous Human Dermal Fibroblas ...	Morphea;Scleroderma, Localized;Scleroderma	Genetic: FCX-013;Drug: veledimex	Castle Creek Biosciences, LLC.	NULL	Terminated	18 Years	N/A	All	1	Phase 1/Phase 2	United States

First Previous1Next Last